Chugai Pharmabody Research
Priyanka Chichili is a Principal Scientist at Chugai Pharmabody Research, with a tenure that began in August 2017 and encompasses previous roles as Senior Scientist and Researcher. Prior experience includes a position as Research Fellow and Research Assistant at the National University of Singapore from January 2013 to May 2017. Priyanka Chichili holds a Doctor of Philosophy (PhD) in Structural Biology from the National University of Singapore, completed in 2013, and a Bachelor of Technology (B.Tech) in Industrial Biotechnology from Anna University Chennai, obtained in 2006.
This person is not in any offices
Chugai Pharmabody Research
1 followers
In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.